Skip to main content
. 2019 Jun 4;5:74. doi: 10.1186/s40814-019-0451-4

Table 4.

Summary of smoking outcome measure data

Outcome Control Intervention
n Baseline rate Rate at follow-up (95% CI) n Baseline rate Rate at follow-up (95% CI)
4-week quitter (eCO or SC/SA verified) 40 NA 5% (1 to 17%) 40 NA 28% (16 to 43%)
6-month quitter (RS6) 40 NA 5% (1 to 17%) 40 NA 15% (7 to 29%)
n Baseline mean (SD) Mean change from baseline to 6 months (SD; 95% CI) n Baseline mean (SD) Mean change from baseline to 6 months (SD; 95% CI)
eCO (ppm) 29 17.1 (10.4) − 5.8 (12.3; − 10.5 to − 1.1) 29 22.0 (12.8) − 12.0 (11.0; − 16.2 to − 7.9)
FTND 29 4.6 (2.5) − 1.6 (2.1; − 2.4 to − 0.8) 29 4.6 (1.6) − 1.9 (2.0; − 2.7 to − 1.2)
MPSS 29 22.8 (7.5) − 2.8 (8.3; − 6.0 to 0.3) 29 21.8 (4.9) − 2.8 (8.8; − 6.1 to 0.6)
SC (ng/ml) 29 277.2 (131.5) − 37.1 (133.4; − 90.0 to 15.7) 29 326.3 (145.5) − 62.2 (132.3; − 112.5 to − 11.8)
SA (ng/ml) 29 0.8 (0.8) 0.5 (2.3; − 0.5 to 1.4) 29 1.2 (1.3) − 0.4 (1.2; − 0.9 to 0.0)

In line with recommendations for smoking cessation trials [4], participants with missing smoking outcome data (e.g. those not attending for review) were considered as continuing smokers or to have resumed smoking. Hence, the denominator for the 4-week and 6-month quitter outcome is the baseline number of participants (n = 40). For continuous variables, missing data were not imputed

eCO expired air carbon monoxide, RS6 Russell standard 6-month quitter, FTND Fagerstroms test of nicotine dependence, MPSS Mood and Physical Symptoms Scale, SC salivary cotinine, SA salivary anabasine, NA not applicable